Cargando…

Preoperative neutrophil-to-lymphocyte ratio (preNLR) for the assessment of tumor characteristics in lung adenocarcinoma patients with brain metastasis

OBJECTIVES: Brain metastases from lung adenocarcinoma cause significant patient mortality. This study aims to evaluate the role of preoperative Neutrophil-to-Lymphocyte ratio (preNLR) in predicting the survival and prognosis of Lung adenocarcinoma (LUAD) patients with brain metastasis (BM) and provi...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Huanhuan, Yang, Yuechao, Feng, Mingtao, Gao, Yang, Li, Liangdong, Tu, Wenjing, Chen, Xin, Hao, Bin, Li, Sen, Li, Deheng, Chen, Lei, Zhou, Changshuai, Cao, Yiqun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126952/
https://www.ncbi.nlm.nih.gov/pubmed/35598384
http://dx.doi.org/10.1016/j.tranon.2022.101455
_version_ 1784712243372359680
author Cui, Huanhuan
Yang, Yuechao
Feng, Mingtao
Gao, Yang
Li, Liangdong
Tu, Wenjing
Chen, Xin
Hao, Bin
Li, Sen
Li, Deheng
Chen, Lei
Zhou, Changshuai
Cao, Yiqun
author_facet Cui, Huanhuan
Yang, Yuechao
Feng, Mingtao
Gao, Yang
Li, Liangdong
Tu, Wenjing
Chen, Xin
Hao, Bin
Li, Sen
Li, Deheng
Chen, Lei
Zhou, Changshuai
Cao, Yiqun
author_sort Cui, Huanhuan
collection PubMed
description OBJECTIVES: Brain metastases from lung adenocarcinoma cause significant patient mortality. This study aims to evaluate the role of preoperative Neutrophil-to-Lymphocyte ratio (preNLR) in predicting the survival and prognosis of Lung adenocarcinoma (LUAD) patients with brain metastasis (BM) and provide more references for predicting peritumoral edema. METHODS: We retrospectively reviewed 125 LUAD-BM patients who had undergone surgical resection from December 2015 to December 2020. The clinical characteristic, demographic, MRI data, and preNLR within 24–48 h before craniotomy were collected. Patients were divided into two groups based on preNLR (high NLR and low NLR), with cutoff values determined by receiver operating characteristic (ROC) analysis. Association between preoperative NLR and clinical features was determined by using Pearson chi-squared tests. Uni- and multivariate analyzes were performed to compare the overall survival (OS) of clinical features. RESULTS: The patients were divided into NLR-low (64 patients) and NLR-high (61 patients) groups based on receiver operating characteristic analysis of NLR area. According to correlation analysis, a high preNLR (NLR≥2.8) is associated with the both supra- and infratentorial location involved (P = 0.017) and a greater incidence of severe peritumoral edema (P = 0.038). By multivariable analysis, age ≥ 65 years (P = 0.011), KPS < 70 (P = 0.043), elevated preNLR (P = 0.013), extracerebral metastases (P = 0.003), EGFR/ALK+ (P = 0.037), postoperative radiotherapy (P = 0.017) and targeted therapy (P = 0.007) were independent prognostic factors. OS nomogram was constructed based on cox model and model performance was examined (AUC = 0.935). CONCLUSIONS: PreNLR may serve as a prognosis indicator in LUAD patients with brain metastasis, and high preNLR tends to be positively associate with multiple locations and severe peritumoral edema.
format Online
Article
Text
id pubmed-9126952
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Neoplasia Press
record_format MEDLINE/PubMed
spelling pubmed-91269522022-05-26 Preoperative neutrophil-to-lymphocyte ratio (preNLR) for the assessment of tumor characteristics in lung adenocarcinoma patients with brain metastasis Cui, Huanhuan Yang, Yuechao Feng, Mingtao Gao, Yang Li, Liangdong Tu, Wenjing Chen, Xin Hao, Bin Li, Sen Li, Deheng Chen, Lei Zhou, Changshuai Cao, Yiqun Transl Oncol Original Research OBJECTIVES: Brain metastases from lung adenocarcinoma cause significant patient mortality. This study aims to evaluate the role of preoperative Neutrophil-to-Lymphocyte ratio (preNLR) in predicting the survival and prognosis of Lung adenocarcinoma (LUAD) patients with brain metastasis (BM) and provide more references for predicting peritumoral edema. METHODS: We retrospectively reviewed 125 LUAD-BM patients who had undergone surgical resection from December 2015 to December 2020. The clinical characteristic, demographic, MRI data, and preNLR within 24–48 h before craniotomy were collected. Patients were divided into two groups based on preNLR (high NLR and low NLR), with cutoff values determined by receiver operating characteristic (ROC) analysis. Association between preoperative NLR and clinical features was determined by using Pearson chi-squared tests. Uni- and multivariate analyzes were performed to compare the overall survival (OS) of clinical features. RESULTS: The patients were divided into NLR-low (64 patients) and NLR-high (61 patients) groups based on receiver operating characteristic analysis of NLR area. According to correlation analysis, a high preNLR (NLR≥2.8) is associated with the both supra- and infratentorial location involved (P = 0.017) and a greater incidence of severe peritumoral edema (P = 0.038). By multivariable analysis, age ≥ 65 years (P = 0.011), KPS < 70 (P = 0.043), elevated preNLR (P = 0.013), extracerebral metastases (P = 0.003), EGFR/ALK+ (P = 0.037), postoperative radiotherapy (P = 0.017) and targeted therapy (P = 0.007) were independent prognostic factors. OS nomogram was constructed based on cox model and model performance was examined (AUC = 0.935). CONCLUSIONS: PreNLR may serve as a prognosis indicator in LUAD patients with brain metastasis, and high preNLR tends to be positively associate with multiple locations and severe peritumoral edema. Neoplasia Press 2022-05-19 /pmc/articles/PMC9126952/ /pubmed/35598384 http://dx.doi.org/10.1016/j.tranon.2022.101455 Text en © 2022 Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Research
Cui, Huanhuan
Yang, Yuechao
Feng, Mingtao
Gao, Yang
Li, Liangdong
Tu, Wenjing
Chen, Xin
Hao, Bin
Li, Sen
Li, Deheng
Chen, Lei
Zhou, Changshuai
Cao, Yiqun
Preoperative neutrophil-to-lymphocyte ratio (preNLR) for the assessment of tumor characteristics in lung adenocarcinoma patients with brain metastasis
title Preoperative neutrophil-to-lymphocyte ratio (preNLR) for the assessment of tumor characteristics in lung adenocarcinoma patients with brain metastasis
title_full Preoperative neutrophil-to-lymphocyte ratio (preNLR) for the assessment of tumor characteristics in lung adenocarcinoma patients with brain metastasis
title_fullStr Preoperative neutrophil-to-lymphocyte ratio (preNLR) for the assessment of tumor characteristics in lung adenocarcinoma patients with brain metastasis
title_full_unstemmed Preoperative neutrophil-to-lymphocyte ratio (preNLR) for the assessment of tumor characteristics in lung adenocarcinoma patients with brain metastasis
title_short Preoperative neutrophil-to-lymphocyte ratio (preNLR) for the assessment of tumor characteristics in lung adenocarcinoma patients with brain metastasis
title_sort preoperative neutrophil-to-lymphocyte ratio (prenlr) for the assessment of tumor characteristics in lung adenocarcinoma patients with brain metastasis
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126952/
https://www.ncbi.nlm.nih.gov/pubmed/35598384
http://dx.doi.org/10.1016/j.tranon.2022.101455
work_keys_str_mv AT cuihuanhuan preoperativeneutrophiltolymphocyteratioprenlrfortheassessmentoftumorcharacteristicsinlungadenocarcinomapatientswithbrainmetastasis
AT yangyuechao preoperativeneutrophiltolymphocyteratioprenlrfortheassessmentoftumorcharacteristicsinlungadenocarcinomapatientswithbrainmetastasis
AT fengmingtao preoperativeneutrophiltolymphocyteratioprenlrfortheassessmentoftumorcharacteristicsinlungadenocarcinomapatientswithbrainmetastasis
AT gaoyang preoperativeneutrophiltolymphocyteratioprenlrfortheassessmentoftumorcharacteristicsinlungadenocarcinomapatientswithbrainmetastasis
AT liliangdong preoperativeneutrophiltolymphocyteratioprenlrfortheassessmentoftumorcharacteristicsinlungadenocarcinomapatientswithbrainmetastasis
AT tuwenjing preoperativeneutrophiltolymphocyteratioprenlrfortheassessmentoftumorcharacteristicsinlungadenocarcinomapatientswithbrainmetastasis
AT chenxin preoperativeneutrophiltolymphocyteratioprenlrfortheassessmentoftumorcharacteristicsinlungadenocarcinomapatientswithbrainmetastasis
AT haobin preoperativeneutrophiltolymphocyteratioprenlrfortheassessmentoftumorcharacteristicsinlungadenocarcinomapatientswithbrainmetastasis
AT lisen preoperativeneutrophiltolymphocyteratioprenlrfortheassessmentoftumorcharacteristicsinlungadenocarcinomapatientswithbrainmetastasis
AT lideheng preoperativeneutrophiltolymphocyteratioprenlrfortheassessmentoftumorcharacteristicsinlungadenocarcinomapatientswithbrainmetastasis
AT chenlei preoperativeneutrophiltolymphocyteratioprenlrfortheassessmentoftumorcharacteristicsinlungadenocarcinomapatientswithbrainmetastasis
AT zhouchangshuai preoperativeneutrophiltolymphocyteratioprenlrfortheassessmentoftumorcharacteristicsinlungadenocarcinomapatientswithbrainmetastasis
AT caoyiqun preoperativeneutrophiltolymphocyteratioprenlrfortheassessmentoftumorcharacteristicsinlungadenocarcinomapatientswithbrainmetastasis